XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 9 - Earnings Per Share
9 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Earnings Per Share [Text Block]

Note 9 Earnings per Share

 

Basic net income per share is computed based on the weighted average number of common shares outstanding for each period presented. Diluted net income per share reflects the potential dilution that would have occurred if securities to issue common stock were exercised, converted, or resulted in the issuance of common stock that would have then shared in our earnings.

 

The following table summarizes the earnings and the weighted average number of common shares used in the calculation of basic and diluted earnings per share (in thousands, except for share and per share amounts):

 

  

Three Months Ended
September 30

  

Nine Months Ended
September 30

 
  

2022

  

2021

  

2022

  

2021

 

Basic:

                

Weighted average common shares outstanding

  15,445,569   15,364,043   15,438,375   15,347,042 

Net income/(loss) attributable to National HealthCare Corporation

 $(2,429

)

 $(3,348

)

 $16,092  $122,802 

Earnings/(loss) per common share, basic

 $(0.16

)

 $(0.22

)

 $1.04  $8.00 
                 

Diluted:

                

Weighted average common shares outstanding

  15,445,569   15,364,043   15,438,375   15,347,042 

Effects of dilutive instruments

  -   -   38,728   67,641 

Weighted average common shares outstanding

  15,445,569   15,364,043   15,477,103   15,414,683 
                 

Net income/(loss) attributable to National HealthCare Corporation

 $(2,429

)

 $(3,348

)

 $16,092  $122,802 

Earnings/(loss) per common share, diluted

 $(0.16

)

 $(0.22

)

 $1.04  $7.97 

 

In the above table, options to purchase 389,781 and 620,076 shares of our common stock have been excluded for the nine months ended September 30, 2022 and 2021, respectively, due to their anti-dilutive impact.